Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Intracellular reactive oxygen species are small, chemically reactive molecules derived from oxygen and generated within the cell—primarily by mitochondrial respiration, NADPH oxidases, peroxisomes, and other organelles. They act as both signaling molecules regulating processes such as proliferation, differentiation, and apoptosis, and as effectors of cellular damage when present at high concentrations. Dysregulation of intracellular ROS production and removal is implicated in a wide variety of diseases, including cancer, inflammation, neurodegeneration, cardiovascular disease, and aging. While drugs may target pathways that generate or scavenge ROS, "intracellular reactive oxygen species" does not refer to a distinct, molecule-specific therapeutic target[1][2][3].
Scavenging ROS, Inhibiting ROS production, Modulating redox-sensitive signaling pathways, Enhancing ROS for cytotoxic effect (in cancer therapy)
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Reactive oxygen species, intracellular (ROS (contextually, but no specific standardized abbreviation for the intracellular pool)).